Leader Biomedical acquires a stake in Osteo-Pharma

Leader Biomedical acquired a stake in Osteo-Pharma, a promising research-focused start-up based in Oss, the Netherlands. With this investment, Leader Biomedical is now the company’s largest shareholder.

“With Osteo-Pharma joining the Leader Biomedical Group, we will be able to better serve our customers by enhancing our product portfolio and strengthening our position in the orthopaedic market. This is a big step forward towards realising our mission of bringing new technologies to global markets,” said Leo Liyeung, Executive Director Leader Biomedical Group.

Osteo-Pharma focuses on developing pharmaceuticals and medical devices for the orthopaedic market. Its research will focus on improving bone regeneration near the site of a fracture by simultaneously stimulating bone formation and inhibiting bone resorption. This technology would complement Leader Biomedical’s existing portfolio of orthopaedic products, which include allografts, xenografts, bone cement and a range of surgical implants.

“By joining forces with Leader Biomedical we are gaining access to a global network that will enable us to extend our reach into new markets, including high-growth emerging markets,” said Dr Jan Gossen, Founder and CEO of Osteo-Pharma.